Shin-Etsu Polymer Co.,Ltd. (TYO:7970)
1,796.00
-1.00 (-0.06%)
Aug 1, 2025, 3:30 PM JST
Kronos Bio Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
Cash & Equivalents | 41,421 | 44,901 | 42,453 | 46,900 | 48,749 | 47,620 | Upgrade |
Cash & Short-Term Investments | 41,421 | 44,901 | 42,453 | 46,900 | 48,749 | 47,620 | Upgrade |
Cash Growth | -1.95% | 5.77% | -9.48% | -3.79% | 2.37% | 12.01% | Upgrade |
Accounts Receivable | 23,142 | 27,921 | 25,926 | 27,894 | 24,803 | 21,748 | Upgrade |
Other Receivables | 3,870 | 4,065 | 2,823 | 2,723 | 1,911 | 1,405 | Upgrade |
Receivables | 27,012 | 31,986 | 28,749 | 30,617 | 26,714 | 23,153 | Upgrade |
Inventory | 21,018 | 21,927 | 20,212 | 19,630 | 14,897 | 10,875 | Upgrade |
Other Current Assets | 4,299 | 600 | 1,298 | 925 | 585 | 543 | Upgrade |
Total Current Assets | 93,750 | 99,414 | 92,712 | 98,072 | 90,945 | 82,191 | Upgrade |
Property, Plant & Equipment | 48,477 | 49,793 | 44,420 | 33,689 | 27,164 | 22,292 | Upgrade |
Long-Term Investments | 934 | 1,920 | 2,157 | 2,091 | 1,872 | 2,634 | Upgrade |
Goodwill | 57 | 81 | 144 | 199 | 1,574 | - | Upgrade |
Other Intangible Assets | 895 | 897 | 842 | 673 | 727 | 145 | Upgrade |
Long-Term Deferred Tax Assets | 723 | 881 | 501 | 639 | 293 | 810 | Upgrade |
Other Long-Term Assets | 923 | 2 | 2 | 1 | 2 | 1 | Upgrade |
Total Assets | 145,759 | 152,988 | 140,778 | 135,364 | 122,577 | 108,212 | Upgrade |
Accounts Payable | 10,681 | 16,198 | 16,250 | 18,013 | 15,702 | 12,625 | Upgrade |
Accrued Expenses | 3,795 | 4,507 | 3,751 | 4,108 | 3,618 | 3,485 | Upgrade |
Current Income Taxes Payable | 901 | 3,833 | 2,536 | 2,454 | 4,576 | 2,229 | Upgrade |
Other Current Liabilities | 5,608 | 2,028 | 2,333 | 2,914 | 1,811 | 1,296 | Upgrade |
Total Current Liabilities | 20,985 | 26,566 | 24,870 | 27,489 | 25,707 | 19,635 | Upgrade |
Other Long-Term Liabilities | 1,957 | 1,911 | 1,573 | 1,413 | 1,231 | 733 | Upgrade |
Total Liabilities | 24,283 | 29,835 | 27,812 | 30,237 | 28,241 | 21,535 | Upgrade |
Common Stock | 11,635 | 11,635 | 11,635 | 11,635 | 11,635 | 11,635 | Upgrade |
Additional Paid-In Capital | 10,731 | 10,730 | 10,755 | 10,764 | 10,718 | 10,718 | Upgrade |
Retained Earnings | 91,432 | 90,495 | 85,022 | 79,619 | 73,670 | 69,257 | Upgrade |
Treasury Stock | -2,625 | -2,628 | -2,052 | -1,660 | -1,988 | -1,667 | Upgrade |
Comprehensive Income & Other | 10,303 | 12,921 | 7,606 | 4,769 | 301 | -3,266 | Upgrade |
Total Common Equity | 121,476 | 123,153 | 112,966 | 105,127 | 94,336 | 86,677 | Upgrade |
Shareholders' Equity | 121,476 | 123,153 | 112,966 | 105,127 | 94,336 | 86,677 | Upgrade |
Total Liabilities & Equity | 145,759 | 152,988 | 140,778 | 135,364 | 122,577 | 108,212 | Upgrade |
Net Cash (Debt) | 41,421 | 44,901 | 42,453 | 46,900 | 48,749 | 47,620 | Upgrade |
Net Cash Growth | -1.95% | 5.77% | -9.48% | -3.79% | 2.37% | 12.01% | Upgrade |
Net Cash Per Share | 514.90 | 554.05 | 521.82 | 577.93 | 601.92 | 587.57 | Upgrade |
Filing Date Shares Outstanding | 80.45 | 80.44 | 80.74 | 80.97 | 80.6 | 80.9 | Upgrade |
Total Common Shares Outstanding | 80.45 | 80.44 | 80.74 | 80.93 | 80.6 | 80.9 | Upgrade |
Working Capital | 72,765 | 72,848 | 67,842 | 70,583 | 65,238 | 62,556 | Upgrade |
Book Value Per Share | 1510.04 | 1530.94 | 1399.11 | 1298.95 | 1170.46 | 1071.47 | Upgrade |
Tangible Book Value | 120,524 | 122,175 | 111,980 | 104,255 | 92,035 | 86,532 | Upgrade |
Tangible Book Value Per Share | 1498.21 | 1518.78 | 1386.90 | 1288.17 | 1141.91 | 1069.67 | Upgrade |
Order Backlog | - | 531 | 679 | 757 | 678 | 522 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.